|
Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a guided digital review of non-small cell lung carcinoma (NSCLC) specimens stained with the Ventana PD-L1 (SP263) Assay. This is…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
english
|
|
Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides instruction on evaluating the Ventana PD-L1 (SP263) assay in non-small cell lung carcinoma (NSCLC) cases. This is part 2 of a 3…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
english
|
|
Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a brief overview of the Ventana PD-L1 (SP263) assay & staining in non-small cell lung carcinoma (NSCLC) specimens. Please note…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
English
|
|
This episode is part 2 in a series on the PD-L1 (SP142)
assay in non small cell lung cancer. In this episode, Roche Tissue Diagnostics
Medical and Scientific Affairs colleagues Bharathi Vennapusa,…
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
In this episode, Roche Tissue Diagnostics Medical and
Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari Baker, PhD
discuss the PD-L1 (SP142) assay in non-small cell lung cancer. Drs.…
Content Declaration
Keep for 3 Years Language (In English)
English
|